OLYSIO 150 mg Capsules (Simeprevir)for Chronic Hepatitis C
Description of Olysio (Simeprevir)
Olysio is an anti viral medication that prevents certain virus cells from multiplying in your body.
Its use and Indications
Olysio is a Hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (HCV) genotype 1 infection as a component of a combination antiviral treatment regimen.
Limitations of use:
- Olysio monotherapy is not recommended
- Olysio efficacy in combination with peginterferon alfa and ribavirin is substantially reduced in patients infected with HCV genotype 1a with an NS3 Q80K polymorphism at baseline compared to patients infected with hepatitis C virus (HCV) genotype 1a without the Q80k polymorphism.
- Olysio is not recommended with severe hepatic impairment (Child –Pugh class C)
- Olysio is not recommended in patients who have previously failed therapy with a treatment regimen that included Olysio or other protease inhibitors.
For treatment related information, please consult your treating Physician.
Olysio 150 mg capsules are white, marked with “TMC435 150” in black ink. Olysio capsules are packaged in to a bottle containing 28 capsules.
Storage and handling
Store in the original package in order to protect from light. This medicinal product does not require any special temperature storage conditions
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Johnson & Johnson Inc
Mob No: +91 7738100125, +917738151650
E Mail: email@example.com